{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:44:26Z","timestamp":1759941866478},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T00:00:00Z","timestamp":1390867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1208\/s12248-014-9563-1","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T17:37:46Z","timestamp":1390844266000},"page":"311-323","source":"Crossref","is-referenced-by-count":4,"title":["Novel Endogenous Glycan Therapy for Retinal Diseases: Safety, In Vitro Stability, Ocular Pharmacokinetic Modeling, and Biodistribution"],"prefix":"10.1208","volume":"16","author":[{"given":"Shankar","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallika","family":"Palamoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter T. Luchsinger","family":"de Obarrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorababu","family":"Madhura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Meibohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica M.","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,28]]},"reference":[{"key":"9563_CR1","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","volume":"124","author":"DB Rein","year":"2006","unstructured":"Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754\u201360.","journal-title":"Arch Ophthalmol"},{"key":"9563_CR2","first-page":"541","volume":"11","author":"K Zhang","year":"2012","unstructured":"Zhang K, Zhang L, Weinreb RN. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev. 2012;11:541\u201359.","journal-title":"Nat Rev"},{"key":"9563_CR3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.survophthal.2006.05.001","volume":"51","author":"S Haddad","year":"2006","unstructured":"Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol. 2006;51:316\u201363.","journal-title":"Surv Ophthalmol"},{"key":"9563_CR4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrn2007","volume":"7","author":"A Rattner","year":"2006","unstructured":"Rattner A, Nathans J. Macular degeneration: recent advances and therapeutic opportunities. Nat Rev Neurosci. 2006;7:860\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"9563_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"I Bhutto","year":"2012","unstructured":"Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Asp Med. 2012;33:295\u2013317.","journal-title":"Mol Asp Med"},{"key":"9563_CR6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","volume":"20","author":"GS Hageman","year":"2001","unstructured":"Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705\u201332.","journal-title":"Prog Retin Eye Res"},{"key":"9563_CR7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/6509","volume":"5","author":"HJ Kaplan","year":"1999","unstructured":"Kaplan HJ, Leibole MA, Tezel T, Ferguson TA. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med. 1999;5:292\u20137.","journal-title":"Nat Med"},{"key":"9563_CR8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","volume":"99","author":"R Klein","year":"1992","unstructured":"Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933\u201343.","journal-title":"Ophthalmology"},{"key":"9563_CR9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","volume":"120","author":"MG Krzystolik","year":"2002","unstructured":"Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 2002;120:338\u201346.","journal-title":"Arch Ophthalmol"},{"key":"9563_CR10","first-page":"281","volume":"151","author":"N Okamoto","year":"1997","unstructured":"Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol. 1997;151:281\u201391.","journal-title":"Am J Pathol"},{"key":"9563_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02150948","volume":"223","author":"PL Penfold","year":"1985","unstructured":"Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985;223:69\u201376.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9563_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(95)31034-2","volume":"102","author":"JR Vingerling","year":"1995","unstructured":"Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology. 1995;102:205\u201310.","journal-title":"Ophthalmology"},{"issue":"3","key":"9563_CR13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ajo.2008.05.017","volume":"146","author":"E Friedman","year":"2008","unstructured":"Friedman E. The pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2008;146(3):348\u20139.","journal-title":"Am J Ophthalmol"},{"key":"9563_CR14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, O\u2019Colmain BJ, Mu\u00f1oz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564\u201372.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"9563_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S0004-27492012000100016","volume":"75","author":"FM Damico","year":"2012","unstructured":"Damico FM, Gasparin F, Scolari MR, Pedral LS, Takahashi BS. New approaches and potential treatments for dry age-related macular degeneration. Arq Bras Oftalmol. 2012;75(1):71\u20135.","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"9563_CR16","first-page":"775","volume":"40","author":"JT Handa","year":"1999","unstructured":"Handa JT, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty GA, te Koppele JM, et al. Increase in the advanced glycation end product pentosidine in Bruch\u2019s membrane with age. Invest Ophthalmol Vis Sci. 1999;40(3):775\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9563_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1474-9726.2011.00752.x","volume":"11","author":"T Uchiki","year":"2012","unstructured":"Uchiki T, Weikel KA, Jiao W, Shang F, Caceres A, Pawlak D, et al. Glycation-altered proteolysis as a pathobiological mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell. 2012;11:1\u201313.","journal-title":"Aging Cell"},{"key":"9563_CR18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1167\/iovs.11-8545","volume":"53","author":"KA Weikel","year":"2012","unstructured":"Weikel KA, Fitzgerald P, Shang F, Caceres MA, Bian Q, Handa JT, et al. Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets. Invest Ophthalmol Vis Sci. 2012;53:622\u201332.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"9563_CR19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/mp300488s","volume":"10","author":"M Palamoor","year":"2013","unstructured":"Palamoor M, Jablonski MM. Poly(ortho ester) nanoparticle-based targeted intraocular therapy for controlled release of hydrophilic molecules. Mol Pharm. 2013;10(2):701\u20138.","journal-title":"Mol Pharm"},{"key":"9563_CR20","doi-asserted-by":"crossref","unstructured":"Swaminathan S, Jablonski MM. Non-biological membranes as drug delivery systems. J Memb Sci Technol. 2012;2(3):e108.","DOI":"10.4172\/2155-9589.1000e108"},{"issue":"6","key":"9563_CR21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1166\/jbn.2013.1594","volume":"9","author":"S Swaminathan","year":"2013","unstructured":"Swaminathan S, Vavia P, Trotta F, Cavalli R. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment. J Biomed Nanotechnol. 2013;9(6):998\u20131007.","journal-title":"J Biomed Nanotechnol"},{"key":"9563_CR22","unstructured":"Jablonski MM, inventor; The University of Tennessee Research Foundation, assignee. Glycan binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon. USA patent 8092825. 2012 Jan 10, 2012."},{"key":"9563_CR23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1097-0185(20000601)259:2<205::AID-AR10>3.0.CO;2-4","volume":"259","author":"M Jablonski","year":"2000","unstructured":"Jablonski M, Ervin C. A closer look at lactose mediated support of retinal morphogenesis. Anat Rec. 2000;259:205\u201314.","journal-title":"Anat Rec"},{"key":"9563_CR24","first-page":"27","volume":"7","author":"MM Jablonski","year":"2001","unstructured":"Jablonski MM, Iannaccone A. Lactose supports Muller cell protein expression patterns in the absence of the retinal pigment epithelium. Mol Vis. 2001;7:27\u201335.","journal-title":"Mol Vis"},{"key":"9563_CR25","first-page":"16","volume":"5","author":"MM Jablonski","year":"1999","unstructured":"Jablonski MM, Wohabrebbi A. Lactose promotes organized photoreceptor outer segment assembly and preserves expression of photoreceptor proteins in retinal degeneration. Mol Vis. 1999;5:16.","journal-title":"Mol Vis"},{"key":"9563_CR26","doi-asserted-by":"crossref","unstructured":"Fukuda M. Chemical labeling of carbohydrates by oxidation and sodium borohydride reduction. Curr Protoc Mol Biol. 1994;17.5.1\u201317.5.8:Supplement 26.","DOI":"10.1002\/0471142727.mb1705s26"},{"issue":"4","key":"9563_CR27","doi-asserted-by":"crossref","first-page":"e36135","DOI":"10.1371\/journal.pone.0036135","volume":"7","author":"Y Muraoka","year":"2012","unstructured":"Muraoka Y, Ikeda H, Nakano N, Hangai M, Toda Y, Okamoto-Furuta K, et al. Real-time imaging of rabbit retina with retinal degeneration by using spectral-domain optical coherence tomography. PLoS One. 2012;7(4):e36135.","journal-title":"PLoS One"},{"key":"9563_CR28","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1038\/sj.onc.1204876","volume":"20","author":"S Skapek","year":"2001","unstructured":"Skapek S, Lin S, Jablonski M, McKeller R, Tan M, Hu N, et al. Persistent expression of cyclin D1 disrupts normal photoreceptor differentiation and retina development. Oncogene. 2001;20:6742\u201351.","journal-title":"Oncogene"},{"key":"9563_CR29","unstructured":"Bulletin PT. DeadEnd\u2122 Fluorometric TUNEL System: instructions for use of product G3250. Madison, WI, USA."},{"issue":"5","key":"9563_CR30","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.exer.2005.09.018","volume":"82","author":"H Kim","year":"2006","unstructured":"Kim H, Csaky KG, Chan CC, Bungay PM, Lutz RJ, Dedrick RL, et al. The pharmacokinetics of rituximab following an intravitreal injection. Exp Eye Res. 2006;82(5):760\u20136.","journal-title":"Exp Eye Res"},{"issue":"5","key":"9563_CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00006982-200605000-00005","volume":"26","author":"H Kim","year":"2006","unstructured":"Kim H, Csaky KG, Gravlin L, Yuan P, Lutz RJ, Bungay PM, et al. Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina. 2006;26(5):523\u201330.","journal-title":"Retina"},{"issue":"5","key":"9563_CR32","first-page":"1024","volume":"42","author":"L L\u00f3pez\u2013Cort\u00e9s","year":"2001","unstructured":"L\u00f3pez\u2013Cort\u00e9s L, Pastor\u2013Ramos M, Ruiz\u2013Valderas R, Cordero E, Uceda\u2013Monta\u00f1\u00e9s A, Claro\u2013Cala C, et al. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Invest Ophthalmol Vis Sci. 2001;42(5):1024\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9563_CR33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/OPTH.S19555","volume":"5","author":"CI Sinapis","year":"2011","unstructured":"Sinapis CI, Routsias JG, Sinapis AI, Sinapis DI, Agrogiannis GA, Pantopoulou A, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin\u00ae) in rabbits. Clin Ophthalmol. 2011;5:697\u2013704.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"9563_CR34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1167\/iovs.11-8053","volume":"53","author":"J Shahar","year":"2012","unstructured":"Shahar J, Zemel E, Perlman I, Loewenstein A. Physiological and toxicological effects of cefuroxime on the albino rabbit retina. Invest Ophthalmol Vis Sci. 2012;53(2):906\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9563_CR35","first-page":"701","volume":"9","author":"XF Wang","year":"2003","unstructured":"Wang XF, Iannaccone A, Jablonski MM. Permissive glycan support of photoreceptor outer segment assembly occurs via a non-metabolic mechanism. Mol Vis. 2003;9:701\u20139.","journal-title":"Mol Vis"},{"key":"9563_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4615-1897-6_15","volume-title":"Degenerative diseases of the retina","author":"MM Stiemke","year":"1995","unstructured":"Stiemke MM, Hollyfield JG. Effect of sugars on photoreceptor outer segment assembly. In: Anderson RE, Hollyfield JG, LaVail MM, editors. Degenerative diseases of the retina. New York: Plenum; 1995. p. 129\u201337."},{"key":"9563_CR37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/dbio.1994.1076","volume":"162","author":"MM Stiemke","year":"1994","unstructured":"Stiemke MM, Landers RA, Al-Ubaidi MR, Hollyfield JG. Photoreceptor outer segment development in Xenopus laevis: influence of the pigment epithelium. Dev Biol. 1994;162:169\u201380.","journal-title":"Dev Biol"},{"key":"9563_CR38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0014-4835(87)80135-5","volume":"44","author":"HH Varner","year":"1987","unstructured":"Varner HH, Rayborn ME, Osterfeld AM, Hollyfield JG. Localization of proteoglycan within the matrix sheath of cone photoreceptors. Exp Eye Res. 1987;44:633\u201342.","journal-title":"Exp Eye Res"},{"issue":"3","key":"9563_CR39","doi-asserted-by":"crossref","first-page":"e18305","DOI":"10.1371\/journal.pone.0018305","volume":"6","author":"S Ganesh","year":"2011","unstructured":"Ganesh S, Chintala S. Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells. PLoS ONE. 2011;6(3):e18305.","journal-title":"PLoS ONE"},{"key":"9563_CR40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.exer.2005.12.014","volume":"84","author":"V Sarthy","year":"2007","unstructured":"Sarthy V. Focus on molecules: glial fibrillary acidic protein (GFAP). Exp Eye Res. 2007;84:381\u20132.","journal-title":"Exp Eye Res"},{"key":"9563_CR41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-4835(87)80023-4","volume":"44","author":"PA Erickson","year":"1987","unstructured":"Erickson PA, Fisher SK, Guerin CJ, Anderson DH, Kaska DD. Glial fibrillary acidic protein increases in Muller cells after retinal detachment. Exp Eye Res. 1987;44:37\u201348.","journal-title":"Exp Eye Res"},{"key":"9563_CR42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-4835(95)80061-1","volume":"61","author":"NL Barnett","year":"1995","unstructured":"Barnett NL, Osborne NN. Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp Eye Res. 1995;61:83\u201390.","journal-title":"Exp Eye Res"},{"key":"9563_CR43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/glia.20000","volume":"47","author":"E Woldemussie","year":"2004","unstructured":"Woldemussie E, Wijono M, Ruiz G. Muller cell response to laser-induced in intraocular pressure in rats. Glia. 2004;47:109\u201319.","journal-title":"Glia"},{"issue":"4","key":"9563_CR44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"Kerr","year":"1972","unstructured":"Kerr et al. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239.","journal-title":"Br J Cancer"},{"issue":"3","key":"9563_CR45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymeth.2007.11.008","volume":"44","author":"Darzynkiewicz","year":"2008","unstructured":"Darzynkiewicz et al. Analysis of apoptosis by cytometry using TUNEL assay. Methods Enzymol. 2008;44(3):250.","journal-title":"Methods Enzymol"},{"issue":"4","key":"9563_CR46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","volume":"102","author":"A Barber","year":"1998","unstructured":"Barber A, Lieth E, Khin S, Antonetti D, Buchanan A, Gardner T. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Investig. 1998;102(4):783\u201391.","journal-title":"J Clin Investig"},{"issue":"9","key":"9563_CR47","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1124\/dmd.111.040055","volume":"39","author":"RS Kadam","year":"2011","unstructured":"Kadam RS, Jadhav G, Ogidigben M, Kompella UB. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow. Drug Metab Dispos. 2011;39(9):1529\u201337.","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"9563_CR48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.47102\/annals-acadmedsg.V37N7p591","volume":"37","author":"Z Wu","year":"2008","unstructured":"Wu Z, Sadda SR. Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singap. 2008;37(7):591\u20133.","journal-title":"Ann Acad Med Singap"},{"key":"9563_CR49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.preteyeres.2010.04.003","volume":"29","author":"A Laude","year":"2010","unstructured":"Laude A, Tan L, Wilson C, Lascaratos G, Elashry M, Aslam T, et al. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Retin Eye Res. 2010;29:466\u201375.","journal-title":"Prog Retin Eye Res"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-014-9563-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-014-9563-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-014-9563-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T02:38:42Z","timestamp":1688956722000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-014-9563-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,28]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["9563"],"URL":"https:\/\/doi.org\/10.1208\/s12248-014-9563-1","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,28]]}}}